Daniel P. O'Day - 01 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chairman & CEO, Director
Signature: /s/ Amy Kim by Power of Attorney for Daniel O'Day
Issuer symbol: GILD
Transactions as of: 01 Mar 2022
Transactions value $: -$1,400,744
Form type: 4
Filing time: 03 Mar 2022, 18:15:12 UTC
Previous filing: 28 Jan 2022
Next filing: 14 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+11,362	+5.53%		216,716	01 Mar 2022	Direct	F1
transaction	GILD	Common Stock	Options Exercise		+42,922	+19.81%		259,638	01 Mar 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$1,400,743	-23,245	-8.95%	$60.26	236,393	01 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-11,362	-7.53%		139,494	01 Mar 2022	Common Stock	11,362		Direct	F1, F2
transaction	GILD	Restricted Stock Unit	Options Exercise		-42,922	-30.77%		96,572	01 Mar 2022	Common Stock	42,922		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3	The restricted stock units have a three year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested.